Company intelligence / Profile preview

Ardena

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Ardena does not have its own clinical results as it provides contract services for clients’ drug development. It enables preclinical to late-stage clinical programs for biopharma partners by offering integrated CMC/regulatory/bioanalytical/manufacturing solutions

Modalities: Small moleculeslarge molecules/biologicsnanomedicines/nanoparticlestherapeutic peptides and proteinsantibodies and antibody-drug conjugates (ADCs)oligonucleotidesmRNA therapiescell and gene therapies
Industry: Contract Research Organization

Beyond the preview

Go deeper on Ardena.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ardena.

Explore the full profile